Abstract
Purpose
To classify and assess ipsilateral breast tumor recurrences (IBTR) after breast-conserving therapy.
Methods
Between 1986 and 2001, 2,137 patients who had breast cancer underwent breast-conserving surgery with or without radiotherapy at the Cancer Institute Hospital of the Japanese Foundation for Cancer Research. Of these patients, 83 (3.9%) had an IBTR. We classified the IBTR as a new primary cancer (NP) if the primary tumor had completely negative margins at first operation by detailed pathological examination and if the IBTR had an intraductal component. All other IBTRs were judged true local recurrence (TR).
Results
Of the 83 patients, 42 patients were classified as TR (29 had no radiotherapy) and 41 as NP (40 had no radiotherapy). Mean time to disease recurrence was 37 months for TR (52% were within 2 years) versus 55 months for NP (19% were within 2 years) (p= 0.031). Six patients (14%) with TR did not receive re-operation, and 67% received salvage mastectomy and 19% re-lumpectomy. All cases of NP were operable, 78% underwent salvage mastectomy and 22% underwent re-lumpectomy. Distant metastases were observed in 33% of patients with TR and 5% of patients with NP, and cause-specific death occurred in 6 cases with TR and in one with NP. The patients with NP had improved 5-year rates of overall survival (NP 91% vs. TR 76%,P= 0.0627) and distant disease-free survival (NP 93% vs. TR 61%,P= 0.0028). Patients with NP more often developed contralateral breast cancer (NP 37% vs. TR 12%,P= 0.018)
Conclusions
Patients with NP had better survival rates than those with TR. Distinguishing new primary breast carcinomas from local disease recurrences may have importance in therapeutic decisions and chemoprevention strategies.
Similar content being viewed by others
References
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med 347:1227–1232, 2002.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med 347:1233–1241, 2002.
Harris JR, Vicini FA: 45th Annual meeting of the American Society Therapeutic Radiology and Oncology ASTRO breast cancer: Multidisciplinary breast cancer management — part II : Radiation Issues, Course 309, 2003.
Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN: A prognostic index for ductal carcinoma in situ of the breast.Cancer 77:2267–2274, 1996.
Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirzab NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK: Classifying local disease recurrences after breast coservation therapy based on location and histology.Cancer 95:2059–2067, 2002.
Smith TE, Daesung L, Turner BC, Carter D, Haffty BG: True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathological differences and their implications in natural history, prognosis, and therapeutic management.Int J Radiat Oncol Biol Phys 48:1281–1289, 2000.
Takahashi K, Makita M, Tada T, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G: Breast conseving treatment without radiotherapy.Biomed Pharmac 56:201–204, 2002.
Salvadori B, Marubini E, Miceli R, Conti AR, Cusumano F, Adnreola S, Zucali R, Veroneci U: Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery.Bri J Surg 86:84–87, 1999.
Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, Hans D, Pollet JF, Bressac C, Spitalier JM: Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis.Cancer 63:1912–1917, 1989.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nishimura, S., Takahashi, K., Akiyama, F. et al. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: New primary cancer allows a good prognosis. Breast Cancer 12, 112–117 (2005). https://doi.org/10.2325/jbcs.12.112
Issue Date:
DOI: https://doi.org/10.2325/jbcs.12.112